IDEXX Laboratories EPS - Earnings per Share 2010-2024 | IDXX

IDEXX Laboratories earnings per share (EPS) for the twelve months ending June 30, 2024 was $10.09, a 7.11% increase year-over-year.

  • IDEXX Laboratories EPS for the quarter ending June 30, 2024 was $2.44, a 8.61% decline year-over-year.
  • IDEXX Laboratories 2023 annual EPS was $10.06, a 25.28% increase from 2022.
  • IDEXX Laboratories 2022 annual EPS was $8.03, a 6.63% decline from 2021.
  • IDEXX Laboratories 2021 annual EPS was $8.6, a 28.17% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

IDEXX Laboratories EPS - Earnings per Share 2010-2024 | IDXX

  • IDEXX Laboratories EPS for the quarter ending June 30, 2024 was $2.44, a 8.61% decline year-over-year.
  • IDEXX Laboratories 2023 annual EPS was $10.06, a 25.28% increase from 2022.
  • IDEXX Laboratories 2022 annual EPS was $8.03, a 6.63% decline from 2021.
  • IDEXX Laboratories 2021 annual EPS was $8.6, a 28.17% increase from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$233.2B
Intuitive Surgical (ISRG)$171.7B
Alcon (ALC)$47.9B
IQVIA Holdings (IQV)$43.7B
Edwards Lifesciences (EW)$40.5B
DexCom (DXCM)$27.6B
STERIS (STE)$23.8B
SONOVA HOLDING (SONVY)$21.2B
Waters (WAT)$19.5B
Hologic (HOLX)$19B
Sysmex ADR (SSMXY)$12.6B
Fresenius Medical Care AG KGaA (FMS)$12.3B
Teleflex (TFX)$11.4B
Globus Medical (GMED)$9.4B
Penumbra (PEN)$7.3B
Glaukos (GKOS)$6.7B
Masimo (MASI)$6.1B
TransMedics (TMDX)$5.2B
Integer Holdings (ITGR)$4.2B
PROCEPT BioRobotics (PRCT)$4.1B
Tandem Diabetes Care (TNDM)$2.8B
LivaNova (LIVN)$2.8B
Veracyte (VCYT)$2.6B
Inari Medical (NARI)$2.6B
Elekta AB (EKTAY)$2.5B
Nihon Kohden (NHNKY)$2.5B
RxSight (RXST)$2.1B
Integra LifeSciences Holdings (IART)$1.3B
Pulse Biosciences (PLSE)$1.2B
OPKO Health (OPK)$1.2B